Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of <scp>CGRP</scp> ‐Related Therapies in Moyamoya Angiopathy”
Authors
Markus Wiedmann (ORCID: https://orcid.org/0000-0002-4172-4115)
Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP ‐Related Therapies in Moyamoya Angiopathy”
Markus Wiedmann, Dominique Hervé, Anna Bersano, Francesco Acerbi et al.
Journal
European Journal of Neurology
Topics
Moyamoya disease diagnosis and treatment
article
Response to the Letter to the Editor: “Reaffirming Caution—The Unacceptable Vasoconstrictive Risk of CGRP ‐Related Therapies in Moyamoya Angiopathy”
Markus Wiedmann, Dominique Hervé, Anna Bersano, Francesco Acerbi, Nicola Rifino, Stéphanie Guey, Jana Becker
article en
Abstract
No abstract available for this paper.
Publication Tag
European Journal of NeurologyVol. 33(1)
Institutions
Oslo University Hospital (NO), Assistance Publique – Hôpitaux de Paris (FR), Hôpital Lariboisière (FR), Alfried Krupp Hospital (DE), Fondazione IRCCS Istituto Neurologico Carlo Besta (IT)